Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rimda Wanchoo

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Kidney International|June 12, 2020
Thrombotic microangiopathy in a patient with COVID-19Kenar D Jhaveri, Lea R Meir, Bessy Suyin Flores Chang, et al.
Clinical Kidney Journal|September 11, 2024
Semaglutide-associated kidney injuryFarhana Begum, Kelly Chang, Krishna Kapoor, et al.
American Journal of Hematology|July 2, 2019
Monoclonal gammopathy-associated thrombotic microangiopathyJennifer C Yui, Daniel Garceau, Kenar D Jhaveri, et al.
Journal of the American Society of Nephrology : JASN|July 15, 2020
COVID-19-Associated Kidney Injury: A Case Series of Kidney Biopsy FindingsPurva Sharma, Nupur N Uppal, Rimda Wanchoo, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 22, 2020
Outcomes Among Patients Hospitalized With COVID-19 and Acute Kidney InjuryJia H Ng, Jamie S Hirsch, Azzour Hazzan, et al.
Kidney International Reports|December 2, 2020
Remdesivir in Patients With Estimated GFR <30 ml/min per 1.73 m<sup>2</sup> or on Renal Replacement TherapyChristopher Estiverne, Ian A Strohbehn, Zain Mithani, et al.
Kidney International|October 25, 2024
Diagnosis and management of immune checkpoint inhibitor-associated nephrotoxicity: a position statement from the American Society of Onco-nephrologySandra M Herrmann, Ala Abudayyeh, Shruti Gupta, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 17, 2025
Nephrotoxicity of Conventional Chemotherapeutics: Part I - Platinum Compounds and Antimetabolite AgentsAdam Kelly, Sourabh Sharma, Omar Mamlouk, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 17, 2025
Nephrotoxicity of Conventional Chemotherapeutics: Part II - Non-Platinum Agents and Miscellaneous Nephrotoxic DrugsAdam Kelly, Sourabh Sharma, Omar Mamlouk, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 7, 2024
Assessment of GFR in Patients with Cancer: A Statement from the American Society of Onco-NephrologyAbhijat Kitchlu, Verônica T Costa E Silva, Shuchi Anand, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Kidney International|June 12, 2020
Thrombotic microangiopathy in a patient with COVID-19Kenar D Jhaveri, Lea R Meir, Bessy Suyin Flores Chang, et al.
Clinical Kidney Journal|September 11, 2024
Semaglutide-associated kidney injuryFarhana Begum, Kelly Chang, Krishna Kapoor, et al.
American Journal of Hematology|July 2, 2019
Monoclonal gammopathy-associated thrombotic microangiopathyJennifer C Yui, Daniel Garceau, Kenar D Jhaveri, et al.
Journal of the American Society of Nephrology : JASN|July 15, 2020
COVID-19-Associated Kidney Injury: A Case Series of Kidney Biopsy FindingsPurva Sharma, Nupur N Uppal, Rimda Wanchoo, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 22, 2020
Outcomes Among Patients Hospitalized With COVID-19 and Acute Kidney InjuryJia H Ng, Jamie S Hirsch, Azzour Hazzan, et al.
Kidney International Reports|December 2, 2020
Remdesivir in Patients With Estimated GFR <30 ml/min per 1.73 m<sup>2</sup> or on Renal Replacement TherapyChristopher Estiverne, Ian A Strohbehn, Zain Mithani, et al.
Kidney International|October 25, 2024
Diagnosis and management of immune checkpoint inhibitor-associated nephrotoxicity: a position statement from the American Society of Onco-nephrologySandra M Herrmann, Ala Abudayyeh, Shruti Gupta, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 17, 2025
Nephrotoxicity of Conventional Chemotherapeutics: Part I - Platinum Compounds and Antimetabolite AgentsAdam Kelly, Sourabh Sharma, Omar Mamlouk, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 17, 2025
Nephrotoxicity of Conventional Chemotherapeutics: Part II - Non-Platinum Agents and Miscellaneous Nephrotoxic DrugsAdam Kelly, Sourabh Sharma, Omar Mamlouk, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 7, 2024
Assessment of GFR in Patients with Cancer: A Statement from the American Society of Onco-NephrologyAbhijat Kitchlu, Verônica T Costa E Silva, Shuchi Anand, et al.
Pageof 7